Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
Rauscher Disappointed In CREG Progress
Cancer Commission Surveying for Pill, Hepatoma Association
President Accepts Rauscher Resignation
NCI Urged To Back Ultrasounds Studies
Schmidt Attempted To Answer Critics
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.” - Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?